Literature DB >> 27364552

Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors.

Fang Li1, Xinjian Liu1, John H Sampson2, Darell D Bigner3, Chuan-Yuan Li4.   

Abstract

Cancer stem-like cells (CSC) are thought to drive brain cancer, but their cellular and molecular origins remain uncertain. Here, we report the successful generation of induced CSC (iCSC) from primary human astrocytes through the expression of defined genetic factors. Combined transduction of four factors, Myc, Oct-4, p53DD, and Ras, induced efficient transformation of primary human astrocytes into malignant cells with powerful tumor-initiating capabilities. Notably, transplantation of 100 transduced cells into nude mice was sufficient for tumor formation. The cells showed unlimited self-renewal ability with robust telomerase activities. In addition, they expressed typical glioma stem-like cell markers, such as CD133, CD15, and CD90. Moreover, these cells could form spheres in culture and differentiate into neuron-like, astrocyte-like, and oligodendrocyte-like cells. Finally, they also displayed resistance to the widely used brain cancer drug temozolomide. These iCSCs could provide important tools for studies of glioma biology and therapeutics development. Cancer Res; 76(17); 5143-50. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27364552      PMCID: PMC5082736          DOI: 10.1158/0008-5472.CAN-16-0171

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  A genetically tractable model of human glioma formation.

Authors:  J N Rich; C Guo; R E McLendon; D D Bigner; X F Wang; C M Counter
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 2.  Cancer stem cells: an evolving concept.

Authors:  Long V Nguyen; Robert Vanner; Peter Dirks; Connie J Eaves
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

3.  Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon.

Authors:  V Tropepe; M Sibilia; B G Ciruna; J Rossant; E F Wagner; D van der Kooy
Journal:  Dev Biol       Date:  1999-04-01       Impact factor: 3.582

4.  A network of genetic events sufficient to convert normal human cells to a tumorigenic state.

Authors:  S DiSean Kendall; Corinne M Linardic; Stacey J Adam; Christopher M Counter
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

5.  Pten haploinsufficiency accelerates formation of high-grade astrocytomas.

Authors:  Chang-Hyuk Kwon; Dawen Zhao; Jian Chen; Sheila Alcantara; Yanjiao Li; Dennis K Burns; Ralph P Mason; Eva Y-H P Lee; Hong Wu; Luis F Parada
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

6.  Self-renewal as a therapeutic target in human colorectal cancer.

Authors:  Antonija Kreso; Peter van Galen; Nicholas M Pedley; Evelyne Lima-Fernandes; Catherine Frelin; Thomas Davis; Liangxian Cao; Ramil Baiazitov; Wu Du; Nadiya Sydorenko; Young-Choon Moon; Lianne Gibson; Yadong Wang; Cherry Leung; Norman N Iscove; Cheryl H Arrowsmith; Eva Szentgyorgyi; Steven Gallinger; John E Dick; Catherine A O'Brien
Journal:  Nat Med       Date:  2013-12-01       Impact factor: 53.440

7.  Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.

Authors:  Thomas S Jacques; Alexander Swales; Monika J Brzozowski; Nico V Henriquez; Jacqueline M Linehan; Zaman Mirzadeh; Catherine O' Malley; Heike Naumann; Arturo Alvarez-Buylla; Sebastian Brandner
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

8.  Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.

Authors:  Dinorah Friedmann-Morvinski; Eric A Bushong; Eugene Ke; Yasushi Soda; Tomotoshi Marumoto; Oded Singer; Mark H Ellisman; Inder M Verma
Journal:  Science       Date:  2012-10-18       Impact factor: 47.728

9.  EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.

Authors:  Qi-Wen Fan; Christine K Cheng; W Clay Gustafson; Elizabeth Charron; Petra Zipper; Robyn A Wong; Justin Chen; Jasmine Lau; Christiane Knobbe-Thomsen; Michael Weller; Natalia Jura; Guido Reifenberger; Kevan M Shokat; William A Weiss
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  13 in total

Review 1.  Overcoming therapeutic resistance in glioblastoma: the way forward.

Authors:  Satoru Osuka; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

2.  Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Ashok Godavarthi; Raghu Chandrashekar
Journal:  Med Oncol       Date:  2017-09-26       Impact factor: 3.064

3.  A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.

Authors:  Changzheng Du; Landon J Hansen; Simranjit X Singh; Feiyifan Wang; Ran Sun; Casey J Moure; Kristen Roso; Paula K Greer; Hai Yan; Yiping He
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.423

4.  MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.

Authors:  Landon J Hansen; Ran Sun; Rui Yang; Simranjit X Singh; Lee H Chen; Christopher J Pirozzi; Casey J Moure; Carlee Hemphill; Austin B Carpenter; Patrick Healy; Ryan C Ruger; Chin-Pu J Chen; Paula K Greer; Fangping Zhao; Ivan Spasojevic; Carole Grenier; Zhiqing Huang; Susan K Murphy; Roger E McLendon; Henry S Friedman; Allan H Friedman; James E Herndon; John H Sampson; Stephen T Keir; Darell D Bigner; Hai Yan; Yiping He
Journal:  Cancer Res       Date:  2019-04-30       Impact factor: 12.701

Review 5.  Multidimensional communication in the microenvirons of glioblastoma.

Authors:  Marike L Broekman; Sybren L N Maas; Erik R Abels; Thorsten R Mempel; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

6.  Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma.

Authors:  Evgeny Deforzh; Erik J Uhlmann; Eashita Das; Aleksandra Galitsyna; Ramil Arora; Harini Saravanan; Rosalia Rabinovsky; Aditya D Wirawan; Nadiya M Teplyuk; Rachid El Fatimy; Sucika Perumalla; Anirudh Jairam; Zhiyun Wei; Leonid Mirny; Anna M Krichevsky
Journal:  Mol Cell       Date:  2022-04-06       Impact factor: 19.328

7.  MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi.

Authors:  Timothy Casselli; Humaira Qureshi; Elizabeth Peterson; Danielle Perley; Emily Blake; Bradley Jokinen; Ata Abbas; Sergei Nechaev; John A Watt; Archana Dhasarathy; Catherine A Brissette
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

8.  Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells.

Authors:  Yanding Zhao; Robert Carter; Sivaraman Natarajan; Frederick S Varn; Duane A Compton; Charles Gawad; Chao Cheng; Kristina M Godek
Journal:  BMC Med Genomics       Date:  2019-05-31       Impact factor: 3.063

9.  Non-canonical roles of apoptotic and DNA double-strand break repair factors in mediating cellular response to ionizing radiation.

Authors:  Chuan-Yuan Li
Journal:  Int J Radiat Biol       Date:  2021-07-14       Impact factor: 2.694

10.  CHD7 promotes proliferation of neural stem cells mediated by MIF.

Authors:  Shigeki Ohta; Tomonori Yaguchi; Hironobu Okuno; Hervé Chneiweiss; Yutaka Kawakami; Hideyuki Okano
Journal:  Mol Brain       Date:  2016-12-13       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.